Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,466.40
-7.90 (-0.54%)
Jul 30, 2026, 3:30 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.18 trillion as of July 30, 2026. Its market cap has decreased by -6.82% in one year.
Market Cap
1.18T
Enterprise Value
1.09T
Revenue
280.68B
Ranking
n/a
PE Ratio
35.16
Stock Price
1,466.40
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.18T, an increase of 78,160.53%. That is a compound annual growth rate of 24.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.18T | -2.96% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.07T |
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 1.07T |
| Laurus Labs | 961.65B |
| Aurobindo Pharma | 915.25B |
| Alkem Laboratories | 678.15B |
| Glenmark Pharmaceuticals | 638.25B |
| Ipca Laboratories | 450.20B |